Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 50268-272

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 50268-272). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (50268 272 13)

Label for Esomeprazole Magnesium Delayed-Release Capsules USP 40 mg by AvPAK. The label states Rx only with a 30-count unit dose carton configuration. Includes storage instructions, usual adult dosage note, and manufacturer details for AvKARE in Pulaski, TN. Features two identical barcode images and revision dates.*

FDA Label Image

Figure1 (Figure1)

Chemical structure of Esomeprazole Magnesium, showing the molecular arrangement including methoxy and methyl groups, nitrogen atoms, and the magnesium ion coordinated with three water molecules.*

FDA Label Image

Figure2 (Figure2)

A line graph showing the percentage maintained over a 6-month period for Esomeprazole magnesium at doses of 40 mg, 20 mg, and 10 mg compared to placebo. The graph includes four lines representing each group, illustrating trends in percentage maintained over months.*

FDA Label Image

Figure3 (Figure3)

A line graph showing the percent of subjects maintained over six months for Esomeprazole Magnesium at 40 mg, 20 mg, and 10 mg doses compared to placebo. The y-axis represents percent maintained, and the x-axis represents months. Higher doses show higher maintenance rates compared to placebo over time.*

FDA Label Image

Figure4 (Figure4)

A line graph showing the percent of patients symptom-free over a 28-day diary period. It compares results for three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo, charting their progress day-by-day.*

FDA Label Image

Figure5 (Figure5)

A line graph showing the percent of patients symptom-free over 28 days of treatment with Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The x-axis represents Diary Day from 0 to 28, and the y-axis represents the percent symptom-free from 0% to 100%. The graph compares symptom relief in three groups over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.